Please login to the form below
Gyroscope
This page shows the latest Gyroscope news and features for those working in and with pharma, biotech and healthcare.
Life sciences and NHS feature in Johnson speech – but Brexit promises predominate
This was an apparent reference to Gyroscope, the company based in the Stevenage biotech cluster near London, which is testing its gene therapy for advanced dry Age-related Macular Degeneration (AMD).
Latest news
-
$450m diagnostics sale will fuel more Syncona biotech funding
This will help frees up its portfolio for new investments. Since 31 March 2019, Syncona has invested £64.1min to its portfolio companies, including gene therapy companies Freeline and Gyroscope and
-
Syncona launches another cell therapy company, Treg specialist Quell
Quell is the tenth life science company founded by Syncona, with other UK-based cell and gene therapy companies on its roster including Gyroscope and Freeline.
-
Gyroscope advances gene therapy platform, merges with Orbit
News mirrors Ocugen and Histogenics merger. UK-based Gyroscope is to merge with Orbit Biomedical to further develop its gene therapy platform for eye diseases. ... will hopefully cure eye diseases that today leave people blind,” said Gyroscope’s
-
Novartis and Syncona back new Swiss biotech Anaveon
These include Freeline, which last year raised £88m to accelerate haemophilia gene therapy, and Gyroscope, which earlier this month dosed its first patient with its gene therapy for dry AMD, and
-
Gyroscope's gene therapy given to first dry AMD patient
it is the first of Gyroscope’s gene therapies to progress into the clinic. ... Building on the research of Gyroscope’s scientific founders, we have been working relentlessly over the last two years to advance our first drug development programme into
More from news
Approximately 1 fully matching, plus 10 partially matching documents found.
Latest Intelligence
-
25 Women Leaders in UK Healthcare
Women trailblazers helping to shape the future of healthcare (Part 1)
-
25 Women Leaders in UK Healthcare (part 2)
One notable exception to that is Soraya Bekkali, president, head of R&D at Gyroscope, a UK firm developing gene therapies for eye diseases. ... Between 2017 and March 2019 Soraya served as CEO and CMO of Gyroscope and led the company successfully to
-
Wearables: the tangible product of the patient revolution
Exact details remain vague, but Apple said in a statement that researchers would be able to ask for access to the accelerometer, microphone, gyroscope and GPS sensors in the iPhone “to
More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest appointments
-
Gyroscope Therapeutics appoints CEO
Dr Soraya Bekkali joins from biotech firm Lysogene. Ophthalmology group Gyroscope Therapeutics has appointed Dr Soraya Bekkali as its chief executive officer and director of its board. ... Gyroscope has a unique translational approach to tackling complex
-
Anne Prener to lead Freeline Therapeutics
She joins from Gyroscope Therapeutics to take up CEO role. London, UK-based gene therapy-focused biopharmaceutical company Freeline Therapeutics has appointed Anne Prener as its new chief executive officer. ... Prior to Gyroscope, Frener served as vice
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Wearable Technology Show 2016 report: wearables that could change healthcare, by Andy Hastie
The glasses connect wirelessly with compatible smartphones and are equipped with an accelerometer, gyroscope, electronic compass, brightness sensor, microphone and camera.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Medical Writer – Creative Healthcare Advertising – New Yo...
-
Highly Competitive Salary, Bonus &Benefits
- Principal Medical Writer, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Medical Writers > Scientific Directors – Medical Communicatio...
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Vaccines writer – career opportunity to move into medcomms from ...
-
Highly competitive salary
- Senior Account Exec > CSD – Medical Communications – UK, Lond...
-
Highly Competitive Salary, Bonus &Benefits
- Scientific Director, MRNA/ Covid 19, Medical Communications, UK
-
Six figure salary
- Account Supervisor – Leading Healthcare Advertising Agency – New...
-
Highly Competitive Salary, Bonus &Benefits
- First trial of a vaccine against Alzheimer’s launches
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- US government to pay $5.3bn for Pfizer‘s Paxlovid
- Roche to present new data for its drug Polivy at the American Society of Hematology’s annual meeting
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’
- Lucid Group: Orange the World
- First trial of a vaccine against Alzheimer’s launches
- New COVID variant causing concern
- PMEA 2021: A Celebration of Excellence in Patient Engagement
- From Academics to Entrepreneurship: How Tech is Revolutionizing the Diagnostics Landscape
- Impetus Digital wins Canada’s Most Admired Corporate Cultures Awards 2021
- Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’
- Biogen’s Aduhelm unlikely to get approval in Europe
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- The pandemic preparedness paradox
- First trial of a vaccine against Alzheimer’s launches
- Good NICE news for Pfizer, but Dendreon drug rejected
PMHub
Iguazu
Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...
Latest intelligence
- Webinar:
- Securing a future for telehealth with immersive market research insights...
- Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
- How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
- Six ways to improve diversity in clinical trials
- Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...
